S&P 500   3,114.99 (+0.07%)
DOW   27,665.24 (+0.06%)
QQQ   202.62 (+0.09%)
AAPL   265.23 (+1.33%)
FB   199.05 (+0.17%)
MSFT   150.00 (+0.10%)
GOOGL   1,325.10 (+0.47%)
AMZN   1,748.82 (-0.67%)
NVDA   208.75 (-0.32%)
MU   46.43 (+0.26%)
BABA   199.87 (+3.16%)
TSLA   331.47 (-0.47%)
T   38.32 (+0.55%)
AMD   39.73 (+0.10%)
ACB   2.44 (-1.61%)
F   8.91 (-0.45%)
NFLX   300.68 (-1.20%)
BAC   33.12 (-0.09%)
S&P 500   3,114.99 (+0.07%)
DOW   27,665.24 (+0.06%)
QQQ   202.62 (+0.09%)
AAPL   265.23 (+1.33%)
FB   199.05 (+0.17%)
MSFT   150.00 (+0.10%)
GOOGL   1,325.10 (+0.47%)
AMZN   1,748.82 (-0.67%)
NVDA   208.75 (-0.32%)
MU   46.43 (+0.26%)
BABA   199.87 (+3.16%)
TSLA   331.47 (-0.47%)
T   38.32 (+0.55%)
AMD   39.73 (+0.10%)
ACB   2.44 (-1.61%)
F   8.91 (-0.45%)
NFLX   300.68 (-1.20%)
BAC   33.12 (-0.09%)
S&P 500   3,114.99 (+0.07%)
DOW   27,665.24 (+0.06%)
QQQ   202.62 (+0.09%)
AAPL   265.23 (+1.33%)
FB   199.05 (+0.17%)
MSFT   150.00 (+0.10%)
GOOGL   1,325.10 (+0.47%)
AMZN   1,748.82 (-0.67%)
NVDA   208.75 (-0.32%)
MU   46.43 (+0.26%)
BABA   199.87 (+3.16%)
TSLA   331.47 (-0.47%)
T   38.32 (+0.55%)
AMD   39.73 (+0.10%)
ACB   2.44 (-1.61%)
F   8.91 (-0.45%)
NFLX   300.68 (-1.20%)
BAC   33.12 (-0.09%)
S&P 500   3,114.99 (+0.07%)
DOW   27,665.24 (+0.06%)
QQQ   202.62 (+0.09%)
AAPL   265.23 (+1.33%)
FB   199.05 (+0.17%)
MSFT   150.00 (+0.10%)
GOOGL   1,325.10 (+0.47%)
AMZN   1,748.82 (-0.67%)
NVDA   208.75 (-0.32%)
MU   46.43 (+0.26%)
BABA   199.87 (+3.16%)
TSLA   331.47 (-0.47%)
T   38.32 (+0.55%)
AMD   39.73 (+0.10%)
ACB   2.44 (-1.61%)
F   8.91 (-0.45%)
NFLX   300.68 (-1.20%)
BAC   33.12 (-0.09%)
Log in

NASDAQ:PRPH - ProPhase Labs Stock Price, Forecast & News

$2.07
-0.09 (-4.17 %)
(As of 12/5/2019 02:19 PM ET)
Today's Range
$2.07
Now: $2.07
$2.07
50-Day Range
$1.66
MA: $1.90
$2.20
52-Week Range
$1.63
Now: $2.07
$4.00
Volume3 shs
Average Volume7,192 shs
Market Capitalization$23.96 million
P/E RatioN/A
Dividend YieldN/A
Beta0.02
ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over-the-counter(OTC) consumer healthcare products, dietary supplements, and other remedies in the United States. The company offers TK Supplements product line include Legendz XL for sexual health; Triple Edge XL, an energy booster and testosterone support; and Super ProstaFlow+ for prostate and urinary health. In addition, the company provides contract manufacturing services of OTC healthcare and dietary supplements products. It markets its products through national chain, regional, specialty, and local retail stores. The company was formerly known as The Quigley Corporation. ProPhase Labs, Inc. was founded in 1989 and is headquartered in Doylestown, Pennsylvania.

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:PRPH
CUSIPN/A
Phone215-345-0919

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$13.13 million
Book Value$1.43 per share

Profitability

Net Income$-1,740,000.00

Miscellaneous

Employees47
Market Cap$23.96 million
Next Earnings Date3/24/2020 (Estimated)
OptionableNot Optionable

Receive PRPH News and Ratings via Email

Sign-up to receive the latest news and ratings for PRPH and its competitors with MarketBeat's FREE daily newsletter.


ProPhase Labs (NASDAQ:PRPH) Frequently Asked Questions

What is ProPhase Labs' stock symbol?

ProPhase Labs trades on the NASDAQ under the ticker symbol "PRPH."

How often does ProPhase Labs pay dividends? What is the dividend yield for ProPhase Labs?

ProPhase Labs declared a dividend on Wednesday, November 20th. Investors of record on Tuesday, December 3rd will be given a dividend of $0.25 per share on Thursday, December 12th. The ex-dividend date of this dividend is Monday, December 2nd. View ProPhase Labs' Dividend History.

How were ProPhase Labs' earnings last quarter?

ProPhase Labs Inc (NASDAQ:PRPH) issued its quarterly earnings data on Monday, August, 12th. The company reported ($0.11) earnings per share (EPS) for the quarter. The firm had revenue of $1.65 million for the quarter. ProPhase Labs had a negative return on equity of 20.48% and a negative net margin of 29.05%. View ProPhase Labs' Earnings History.

When is ProPhase Labs' next earnings date?

ProPhase Labs is scheduled to release their next quarterly earnings announcement on Tuesday, March 24th 2020. View Earnings Estimates for ProPhase Labs.

Has ProPhase Labs been receiving favorable news coverage?

News headlines about PRPH stock have been trending somewhat positive this week, according to InfoTrie. The research firm rates the sentiment of press coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. ProPhase Labs earned a media sentiment score of 0.9 on InfoTrie's scale. They also assigned news coverage about the company a news buzz of 1.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the company's share price in the near term. View News Stories for ProPhase Labs.

Are investors shorting ProPhase Labs?

ProPhase Labs saw a decline in short interest in October. As of October 31st, there was short interest totalling 16,000 shares, a decline of 15.3% from the September 30th total of 18,900 shares. Based on an average daily trading volume, of 2,800 shares, the days-to-cover ratio is currently 5.7 days. Currently, 0.2% of the company's shares are short sold. View ProPhase Labs' Current Options Chain.

Who are some of ProPhase Labs' key competitors?

What other stocks do shareholders of ProPhase Labs own?

Who are ProPhase Labs' key executives?

ProPhase Labs' management team includes the folowing people:
  • Mr. Ted William Karkus, Chairman & CEO (Age 60)
  • Ms. Monica Brady, CFO & Chief Accounting Officer (Age 42)

How do I buy shares of ProPhase Labs?

Shares of PRPH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is ProPhase Labs' stock price today?

One share of PRPH stock can currently be purchased for approximately $2.07.

How big of a company is ProPhase Labs?

ProPhase Labs has a market capitalization of $23.96 million and generates $13.13 million in revenue each year. ProPhase Labs employs 47 workers across the globe.View Additional Information About ProPhase Labs.

What is ProPhase Labs' official website?

The official website for ProPhase Labs is http://www.prophaselabs.com/.

How can I contact ProPhase Labs?

ProPhase Labs' mailing address is 621 NORTH SHADY RETREAT ROAD, DOYLESTOWN PA, 18901. The company can be reached via phone at 215-345-0919 or via email at [email protected]


MarketBeat Community Rating for ProPhase Labs (NASDAQ PRPH)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  87 (Vote Outperform)
Underperform Votes:  113 (Vote Underperform)
Total Votes:  200
MarketBeat's community ratings are surveys of what our community members think about ProPhase Labs and other stocks. Vote "Outperform" if you believe PRPH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PRPH will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/5/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel